Ripple 
$1 has made a significant move by withdrawing its cross-appeal in the XRP lawsuit. This development could play a crucial role in the future of the company’s corporate sales strategies. The potential lifting of the regulatory measures previously imposed by authorities in the U.S. may also directly impact the process. Market experts suggest that Ripple may need to reshape its sales methods within a legal compliance framework.
What Does Ripple’s New Legal Maneuver Mean?
Ripple’s withdrawal from the cross-appeal is seen as a notable turning point in the case. By retracting the appeal, the company prefers to wait for the outcomes of Judge Analisa Torres’ earlier injunction ruling. This decision could establish a new roadmap for how Ripple can conduct its sales to institutional investors.
XRP expert lawyer Bill Morgan remarked that this development could lead Ripple to reshape its future sales policies. The path the company takes in corporate sales will depend on the final court decision and the stance of regulatory authorities. If restrictions are lifted, Ripple may gain the opportunity to sell directly to hedge funds and private equity firms.
Corporate Sales Could Be Reconfigured
Ripple’s existing sales strategies are expected to change in accordance with the new requests presented by the U.S. regulatory agency in court. If the SEC‘s previous injunction is lifted, the company may need to restructure its relationships with institutional investors. This also raises the possibility of developing a new sales model.
In previous assessments by Judge Analisa Torres, it was indicated that some of Ripple’s corporate sales methods could qualify as investment contracts. This definition emphasizes the need for Ripple to determine its future steps within a legal framework. The company is expected to avoid methods similar to those criticized in the past.
Market analysts point out that Ripple should strategically adopt a more transparent and auditable model. There are also comments within the community suggesting that transitioning to a new sales arrangement is essential for both investor confidence and regulatory compliance.
